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ABSTRACT 
A simple, sensItIve and fairly rapid method for the 
determination of noscapine (an opium alkaloid of pharmaceutical 
importance) is described. It is based on the measurement of the 
absorbance of the organic soluble ion association complex formed 
between the noscapine monocation and a bulky counter anion. 
The most suitable system was based on bromocresol green (BCG) 
(pH 3.0). The BCG system exhibits negligible or no interference 
when used for the determination of 38 ppm noscapine in the 
presence of several drug excipients, thus lending themselves as a 
possible procedure for the analysis of this alkaloid In 
pharmaceutical preparations. 
INTRODUCTION 
Noscapine (I) is an important naturally occuring opium alkaloid and 
is present in amounts of 6-11 % of the raw material depending on season 
and locality [1,2]. Unlike morphine and codeine, it has no analgesic 
activity nor abuse potential. Its maj or pharmaceutical actions is its anti-
tussive activity, which has been reported to be equivalent to that of 
codeine [1]. 
Noscapine and its metabolites in plasma have been determined using 
high-performance liquid chromatography (HPLC) [3 -7]. The British 
Pharmacopoiea procedure [8] for the determination of noscapine in 
pharmaceutical preparations is based on non-aqueous titration. This 
m1thod lacks specificity and is not suitable for determination of low 
levels of the alkaloid. 
Simpler alternative methods that uses inexpensive instruments is 
needed for the determination of this pharmaceutically important 
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alkaloid. In this paper, the use of three bulky dyes were investigated as 
anionic counter ions for the formation of noscapine ion-association 
complex whose absorbance can be monitored upon extraction. The 
system were further optimized with respect to pH, choice of solvent., 
counter ion concentration and shaking time. Key analytical 
characteristics of the complexes were compared. Determinations of 
noscapine in the presence of common drug expicients were also 
performed. 
(I) 
EXPERIMENTAL 
Apparatus 
All absorbance measurements were made on a Perkin-Elmer Lambda 
5 UV /Vis Spectrophotometer with a matched quartz cuvettes of 1 cm 
path length. pH measurements of the aqueous phase were done using a 
Corning combination glass electrode (Catalog no. 476530) In 
conjunction with a Corning pH meter Model 21. 
General procedure for extraction-spectrophotometry 
1 ml of counter ion and buffer solution, respectively, were 
transferred into a series of 125-ml separating funnel. Aliquots of 1.0 
millimolar alkaloid solution were next added to the funnels. The total 
volume of the aqueous phase was adjusted to 5 ml by the addition of 
distilled water. Finally, 10 ml extraction solvent was added to each 
funnel and the contents shaken vigorously for 60 seconds and was then 
allowed to stand for a few minutes until the two phases had completely 
separated. The absorbance of the separated organic layer was measured 
at their respective Amax against a reagent blank. At least a duplicate 
was made for all measurements. 
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RESULTS AND DISCUSSION 
The most suitable extraction conditions was found to be : 
BeG: extracting solvent (chloroform or dichloromethane), pH 3.0. 
In all instances, a shaking time of 60 seconds and counter-ion 
concentration of 1 mM was adopted. 
Linearity of the calibration graph was studied at the above conditions 
for the respective counter-ions. The analytical characteristics of the 
extraction is summerized in Table 1. 
Table l. Characteristics of noscapine-bromocresol green complex 
Amax = 413 nm 
Molar absorptivity/ mol- 1 cm- 1 = 9100 
Detection limit = 1.6 mg L-l 
Dynamic linear range = 5-60 mg L-1 
The detection limit was calculated as described earlier [9] using the 
equation 3 Sd/S where Sd is the standard deviation of the blank and S is 
the corresponding slope of the calibration graph. The upper and lower 
limit of the dynamic linear range of concentration was estimated from 
the calibration graph, noting when the points start to deviate from the 
straight line. The molar absorptivity of the ion-association systems 
obtained are comparable to those based on phenothiazine derivatives [9] 
and anti-inflammatory drugs [10] described earlier. The table reveals 
that the most sensitive counter ion is BeG. The use of chloroform was 
chosen as the extracting solvent due to its lower volatility for 
application studies. The BCG-based ion association complex is not only 
the most sensitive but also exhibits the lowest detection limit and the 
widest dynamic linear concentration range (Table 1). 
Determination of noscapine 
Interferences from some common drug excipients were examined. It 
was found that these compounds exhibit minimum interference, even 
when present at fifty times the level of noscapine. Determination of 38 
ppm noscapine in a mixture containing 380 ppm each of ascorbic acid, 
citric acid, glucose, magnesium sulfate and starch are also satisfactory. 
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The relative standard deviation of five determinations of 38 ppm 
noscapine was found tpnlDe 0.50. 
CONCLUSION 
An extractive spectrophotometric procedure for the determination of 
noscapine was developed based on BCG with chloroform as the 
extracting solvent. The proposed procedure is fairly rapid, simple, 
sensitive and accurate and promised good prospects for the analysis of 
noscapine in pharmaceutical preparations. Additionally, the method 
uses cheaper instrumentation as compared to HPLC. 
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